There are plans to locate several research groups in Barcelona Science Park’s (PCB) facilities, in a new measure to deal with the institution’s space1
The selected projects were coordinated by Manel Juan, head of the Immunogenetics and Immunotherapy in Autoinflammatory and Immune Responses group and1
This is confirmed by a study conducted by IDIBAPS-Hospital Clínic Barcelona and IDIAPJGol and published in the journal Frontiers in Endocrinology.
IDIBAPS successfully and positively achieved its first reaccreditation in 2014, and its second in 2019.
On 27 June 2024, a social return event was held at the TV3 facilities, thanking the public for the television marathon devoted to cancer.
The investiture ceremony took place on 18 June at the University of Toulouse III - Paul Sabatier.
Head of the IDIBAPS Liver vascular biology research group, his research focuses on the study of hepatic vascular pathophysiology in acute and chronic1
Dr. Llovet (Clínic-IDIBAPS) and Dr. Bustelo (CSIC-University of Salamanca) coordinate the ASPIRE-AECC project, which includes 15 hospitals to conduct1
The stemTIME project, led by Dr. Silvia Affo from IDIBAPS, investigates how cancer stem cells influence the tumor and immune microenvironment in intr1
The conference held at the Paranimf of the Faculty of Medicine of the University of Barcelona featured presentations and talks on topics such as know1
